MGO Private Wealth LLC Sells 11,259 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

MGO Private Wealth LLC lessened its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 70.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,797 shares of the exchange traded fund’s stock after selling 11,259 shares during the period. MGO Private Wealth LLC’s holdings in SPDR S&P Biotech ETF were worth $428,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the stock. Verity Asset Management Inc. boosted its stake in SPDR S&P Biotech ETF by 7.9% in the 3rd quarter. Verity Asset Management Inc. now owns 17,228 shares of the exchange traded fund’s stock worth $1,258,000 after purchasing an additional 1,266 shares in the last quarter. Prime Capital Investment Advisors LLC grew its holdings in shares of SPDR S&P Biotech ETF by 52.6% during the fourth quarter. Prime Capital Investment Advisors LLC now owns 6,464 shares of the exchange traded fund’s stock worth $577,000 after buying an additional 2,228 shares in the last quarter. Sequoia Financial Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $533,000. International Assets Investment Management LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $10,587,000. Finally, United Capital Management of KS Inc. boosted its position in shares of SPDR S&P Biotech ETF by 1.8% during the 4th quarter. United Capital Management of KS Inc. now owns 104,048 shares of the exchange traded fund’s stock valued at $9,290,000 after acquiring an additional 1,831 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 1.5 %

NYSEARCA XBI traded up $1.27 during trading hours on Friday, reaching $83.49. The company had a trading volume of 10,452,779 shares, compared to its average volume of 11,723,970. The stock has a 50-day moving average of $92.69 and a 200 day moving average of $84.72. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52. The stock has a market capitalization of $6.49 billion, a P/E ratio of 11.47 and a beta of 1.08.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.